Escherichia coli st131, an intriguing clonal group

Clinical Microbiology Reviews

Volumn 27, Issue 3, 2014, Pages 543-574

  Nicolas Chanoine, Marie Hélène ^a,b,c   Bertrand, Xavier ^d,e   Madec, Jean Yves ^f  

^a BEAUJON HOSPITAL   (France)

^b Institut National de la Santé et de la Recherche Médicale U773 Centre de Recherche Biomédicale Bichat Beaujon ^*

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^f FRENCH AGENCY FOR FOOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE MUTATION; GENOMICS; HUMAN; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; ANIMAL; CLASSIFICATION; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; RISK FACTOR; VIRULENCE;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOMICS; HUMANS; RISK FACTORS; VIRULENCE;

EID: 84903616595     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00125-13     Document Type: Article

References (246)

1. Croxen MA, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38. http://dx.doi.org/10.1038 /nrmicro2265.
2. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlook epidemic. Microbes Infect. 5:449-456. http://dx.doi.org/10.1016/S1286-4579(03)00049-2.
3. Gupta K, Scholes D, Stamm WE. 1999. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281:736-738. http://dx.doi.org/10.1001/jama.281.8.736.
4. Jones RN, Kehrberg EN, Erwin ME, Anderson SC. 1994. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group Diagn. Microbiol. Infect. Dis. 19:203-215.
5. Turnidge J. 1995. Epidemiology of quinolone resistance. Eastern hemisphere. Drugs 49:43-47.
6. Hummers-Pradier E, Koch M, Ohse AM, Heizmann WR, Kochen MM. 2005. Antibiotic resistance of urinary pathogens in female general practice patients. Scand. J. Infect. Dis. 37:256-261. http://dx.doi.org/10.1080/00365540410021009.
7. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill. 13(47): pii_19044.
8. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park Y-J, Lavigne J-P, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281. doi:10.1093/jac/dkm464.
9. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. http://dx.doi.org/10.3201/eid1402.070350.
10. Johnson JR, Brian J, Connie C, Kuskowski MA, Mariana C. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294. http://dx.doi.org/10.1086/653932.
11. Donnenberg M. 2002. Escherichia coli: virulence mechanism of a versatile pathogen. Academic Press, New York, NY.
12. Escobar-Paramo P, Grenet K, Le Menac'h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Raymond R. 2004. Large-scale population structure of human commensal Escherichia coli isolates. Appl. Environ. Microbiol. 70:5698-5700. http://dx.doi.org/10.1128/AEM.70.9.5698-5700.2004.
13. Escobar-Paramo P, Le Menac'h A, Le Gall T, Amorin C, Gouriou S, Picard B, Skurnik D, Denamur E. 2006. Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates. Environ. Microbiol. Rep. 8:1975-1984. http://dx.doi.org/10.1111/j.1462-2920.2006.01077.x.
14. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O. 2007. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 24:2373-2384. http://dx.doi.org/10.1093/molbev/msm172.
15. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277. http://dx.doi.org/10.1093/jac/dkp194.
16. Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentre F, Jarlier V, Nicolas-Chanoine M-H. 2012. Phylogenetic distribution of CTX-M-and non-extendedspectrum β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 50:2974-2981. http://dx.doi.org/10.1128/JCM.00919-12.
17. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. 2011. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J. Antimicrob. Chemother. 66:2501-2508. http://dx.doi.org/10.1093/jac/dkr349.
18. Dahbi G, Mora A, Lopez C, Alonso MP, Mamani R, Marzoa J, Coira A, Garicia-Garrote F, Pita J-M, Velasco D, Herrera A, Viso S, Blanco JE, Blanco M, Blanco J. 2013. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases Int. J. Antimicrob. Agents. 42:347-351. http://dx.doi.org/10.1016/j.ijantimicag.2013.06.017.
19. Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S. 2012. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extendedspectrum β-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 67:2612-2620. http://dx.doi.org/10.1093/jac/dks278.
20. Olesen B, Hansen DS, Nilsson F, Frimodt-Moller J, Leihof RF, Struve C, Scheutz F, Johnston B, Krogfelt KA, Johnson JR. 2013. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum β-lactamase-producing E. coli isolates in Copenhagen, Denmark. J. Clin. Microbiol. 51:1779-1785. http://dx.doi.org/10.1128/JCM.00346-13.
21. Platell JL, Cobbold RN, Johnson JR, Heisig A, Heisig P, Clabots C, Kuskowski MA, Trott DJ. 2011. Commonality among fluoroquinoloneresistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob. Agents Chemother. 55:3782-3787. http://dx.doi.org/10.1128/AAC.00306-11.
22. Kudinha T, Johnson JR, Andrew S, Kong F, Anderson P, Gilbert GL. 2013. Escherichia coli sequence type 131 (ST131) as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J. Clin. Microbiol. 51:3270-3276. http://dx.doi.org /10.1128/JCM.01315-13.
23. Habeeb MA, Haque A, Iversen A, Giske CG. 14 September 2013. Occurrence of virulence genes, 16S rRNA methylases, and plasmidmediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. Eur. J. Clin. Microbiol. Infect. Dis. http://dx.doi.org /10.1007/s10096-013-1970-1.
24. Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec J-Y, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastasy M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH. 8 January 2014. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J. Antimicrob. Chemother. http://dx.doi.org/10.1093/jac/dkt519.
25. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y. 2009. Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63:72-79. http://dx.doi.org/10.1093/jac/dkn463.
26. Russo TA, Johnson JR. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754. http://dx.doi.org/10.1086/315418.
27. van der Bij AK, Peirano G, Pitondo-Silva A, Pitout JDD. 2012. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn. Microbiol. Infect. Dis. 72:297-302. http://dx.doi.org/10.1016/j.diagmicrobio.2011.12.011.
28. Karisik E, Ellington MJ, Livermore DM, Woodford N. 2008. Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum β-lactamases in the UK. J. Antimicrob. Chemother. 61:54-58. http://dx.doi.org/10.1093/jac/dkm401.
29. Mora A, Blanco M, Lopez C, Mamani R, Blanco JE, Alonso MP, Garcia-Garrote F, Dahbi G, Herrera A, Fernandez A, Fernandez B, Agulla A, Bou G, Blanco J. 2011. Emergence of clonal groups O1:HNMD-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int. J. Antimicrob. Agents. 37:16-21. http://dx.doi.org/10.1016/j.ijantimicag.2010.09.012.
30. CTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370. http://dx.doi.org/10.1128 /AAC.05824-11.
31. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine M-H. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. http://dx.doi.org/10.1371/journal.pone.0034294.
32. Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernandez V, de la Cruz F, Martinez-Martinez L, Alonso MP, Nicolas-Chanoine M-H, Johnson JR, Johnston B, Lopez-Cerero L, Pascual A, Rodriguez-Bano J. 2013. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 51:3358-3367. http://dx.doi.org/10.1128/JCM.01555-13.
33. Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168. http: //dx.doi.org/10.1128/AAC.47.7.2161-2168.2003.
34. Mora Gutierrez A, Dahbi G, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso PM, Denamur E, Blanco J. 2014. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One 9:e87025. http://dx.doi.org/10.1371/journal.pone.0087025.
35. Mora A, Herrera A, Mamani R, Lopez C, Alonso MP, Blanco JE, Blanco M, Dahbi G, Garcia-Garrote F, Pita JM, Coira A, Bernardez MI, Blanco J. 2010. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl. Environ. Microbiol. 76:6991-6997. http://dx.doi.org/10.1128/AEM.01112-10.
36. Johnson JR, Nicolas-Chanoine M-H, DebRoy C, Castanheira M, Robiscek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA, The MASTER Investigators. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg. Infect. Dis. 18:598-607. http: //dx.doi.org/10.3201/eid1804.111627.
37. Johnson JR, O'Bryan TT, Delavari P, Kuskowski M, Stapleton A, Carlino U, Russo TA. 2001. Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J. Infect. Dis. 183:1508-1517. http://dx.doi.org/10.1086/320198.
38. Diaz MA, Hernandez-Bello JR, Rodriguez-Bano J, Martinez-Martinez L, Calvo J, Blanco J, Pascual A. 2010. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. J. Clin. Microbiol. 48:2840-2845. http://dx.doi.org/10.1128 /JCM.02147-09.
39. Tartof SY, Solberg OD, Riley LW. 2007. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs). J. Med. Microbiol. 56:1363-1369. http://dx.doi.org/10.1099/jmm.0.47262-0.
40. Weissman S, Chattopadhyay S, Aprikian P, Obata-Yasuoka M, Yarova-Yarovaya Y, Stapleton A, Ba-Theim W, Dydhuizen D, Johnson J, Sokurenko E. 2006. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol. Microbiol. 59:975-988. http://dx.doi.org/10.1111/j.1365-2958.2005.04985.x.
41. Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Scholes D, Chattopadhyay S, Sokurenko E. 2012. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 78:1353-1360. http://dx.doi.org/10.1128 /AEM.06663-11.
42. Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW. 2013. Clonal composition and community clustering of drug-susceptible and-resistant Escherichia coli isolates from bloodstream infections. Antimicrob. Agents Chemother. 57:490-497. http://dx.doi.org/10.1128/AAC.01025-12.
43. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine M-H, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928. http://dx.doi.org/10.1093 /infdis/jis933.
44. Tchesnokova V, Billig M, Chattopadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova V, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV. 2013. Predictive diagnostics for infections based on the clonal association of antimicrobial resistance and clinical outcome. J. Clin. Microbiol. 51:2991-2999. http://dx.doi.org/10.1128 /JCM.00984-13.
45. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR. 2013. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin. Infect. Dis. 57: 1256-1265. http://dx.doi.org/10.1093/cid/cit503.
46. Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV, Johnson JR. 2013. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob. Agents Chemother. 57:5912-5917. http://dx.doi.org/10.1128/AAC.01065-13.
47. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
48. Clermont O, Christenson JK, Denamur E, Gordon DM. 2013. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5:58-65. http://dx.doi.org/10.1111/1758-2229.12019.
49. Clermont O, Johnson JR, Menard M, Denamur E. 2007. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn. Microbiol. Infect. Dis. 57:214-223.
50. Johnson JR, Menard E, Johnston B, Kuskowski MA, Nichol KA, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739. http://dx.doi.org/10.1128/AAC.00297-09.
51. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612. http://dx.doi.org/10.1128/JCM.00640-08.
52. Golding GR, Persaud N, Levett PN, McDonald RR, Irvine J, Nsungu M, Woods S, Khan M, Mataseje LF, Mulvey MR. 2012. Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: the Northern Antibiotic Resistance Partnership. Diagn. Microbiol. Infect. Dis. 74:242-247. http://dx.doi.org/10.1016/j.diagmicrobio.2012.07.003.
53. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46:3900-3905. http://dx.doi.org/10.1128/JCM.00734-08.
54. Lopez-Cerero L, Navarro MD, Bellido M, Martin-Pena A, Vinas L, Cisneros JM, Gomez-Langley SL, Sanchez-Monteseirin H, Morales I, Pascual A, Rodriguez-Bano J. 11 October 2013. Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. J. Antimicrob. Chemother. http://dx.doi.org/10.1093/jac/dkt405.
55. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53:4472-4482. http://dx.doi.org/10.1128/AAC.00688-09.
56. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A. 2009. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 117:526-536. http://dx.doi.org/10.1111/j.1600-0463.2009.02465.x.
57. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A. 2010. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin. Microbiol. Infect. 16:171-178. http://dx.doi.org/10.1111/j.1469-0691.2009.02861.x.
58. Montesinos I, Rodriguez-Villalobos H, De Mendonca R, Bogaerts P, Deplano A, Glupczynski Y. 2010. Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum β-lactamase associated with the ST131 Escherichia coli clone in Belgium. J. Antimicrob. Chemother. 65:1828-1830. http://dx.doi.org/10.1093/jac/dkq208.
59. CTX-M genes in different plasmids from German clinical Escherichia coli isolates. J. Med. Microbiol. 59:580-587. http://dx.doi.org/10.1099/jmm.0.016188-0.
60. CTX-M-65 is carried by a Tn1722-like element on an IncN conjugative plasmid of ST131 Escherichia coli. J. Med. Microbiol. 60:435-441. http://dx.doi.org/10.1099 /jmm.0.026997-0.
61. CTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J. Antimicrob. Chemother. 66:1263-1268. http://dx.doi.org/10.1093/jac/dkr106.
62. CTX-M-15 and qnrS1 genes. Antimicrob. Agents Chemother. 56:2763-2766. http://dx.doi.org/10.1128 /AAC.06001-11.
63. CTX-M-15 from an Escherichia coli ST131 isolate. Antimicrob. Agents Chemother. 55:5933-5935. http://dx.doi.org/10.1128/AAC.00639-11.
64. Bonnin RA, Poirel L, Carattoli A, Nordmann P. 2012. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 7:34752. http://dx.doi.org/10.1371/journal.pone.0034752.
65. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529. http://dx.doi.org /10.1093/jac/dkq347.
66. Johnson TJ, Nolan LK. 2009. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol. Mol. Biol. Rev. 73:750-774. http://dx.doi.org/10.1128/MMBR.00015-09.
67. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ, Fox AJ, Upton M. 2008. UK epidemic Escherichia coli strains A-E, with CTXM-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J. Antimicrob. Chemother. 62:1241-1244. http://dx.doi.org/10.1093/jac /dkn380.
68. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-termcare facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48: 3758-3764. http://dx.doi.org/10.1128/AAC.48.10.3758-3764.2004.
69. Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N. 2006. Molecular characterization of plasmids encoding CTXM-15 β-lactamases from Escherichia coli strains in the United Kingdom. J. Antimicrob. Chemother. 58:665-668. http://dx.doi.org/10.1093/jac /dkl309.
70. CTX-M in Escherichia coli. Antimicrob. Agents Chemother. 49:447-450. http://dx.doi.org/10.1128/AAC.49.1.447-450.2005.
71. Cao X, Cavaco LM, Lv Y, Li Y, Zheng B, Wang P, Hasman H, Liu Y, Aarestrup FM. 2011. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J. Clin. Microbiol. 49:2496-2501. http://dx.doi.org/10.1128/JCM.02503-10.
72. Hrabak J, Empel J, Bergerova T, Fajfrlik K, Urbaskova P, Kern-Zdanowicz I, Hryniewicz W, Gniadkowski M. 2009. International clones of Klebsiella pneumoniae and Escherichia coli with extendedspectrum β-lactamases in a Czech hospital. J. Clin. Microbiol. 47:3353-3357. http://dx.doi.org/10.1128/JCM.00901-09.
73. Hussain A, Ewers C, Nandanwar N, Guenther S, Jadhav S, Wieler LH, Ahmed N. 2012. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTXM-15 extended-spectrum-β-lactamase-producing lineage. Antimicrob. Agents Chemother. 56:6358-6365. http://dx.doi.org/10.1128/AAC.01099-12.
74. Matsumura Y, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S. 2013. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups. Antimicrob. Agents Chemother. 57:4736-4742. http://dx.doi.org/10.1128/AAC.00641-13.
75. Seiffert SN, Hilty M, Kronenberg A, Droz S, Perreten V, Endimiani A. 2013. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland. J. Antimicrob. Chemother. 68:2249-2254. http://dx.doi.org/10.1093/jac/dkt208.
76. Mnif B, Harhour H, Jdidi J, Mahjoubi F, Genel N, Arlet G, Hammami A. 2013. Molecular epidemiology of extended-spectrum β-lactamaseproducing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems. BMC Microbiol. 13:147. http://dx.doi.org/10.1186/1471-2180-13-147.
77. Dimude JU, Amyes SG. 2013. Molecular diversity associated with the dissemination of CTX-M-15 β-lactamase gene in blood culture isolates of Escherichia coli from Edinburgh. Scand. J. Infect. Dis. 45:32-37. http: //dx.doi.org/10.3109/00365548.2012.708781.
78. Dhanji H, Doumith M, Rooney PJ, O'Leary MC, Loughrey AC, Hope R, Woodford N, Livermore DM. 2011. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum β-lactamases in nursing homes in Belfast, UK. J. Antimicrob. Chemother. 66:297-303. http://dx.doi.org/10.1093/jac/dkq463.
79. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362. http://dx.doi.org/10.1016/S1473-3099(11)70059-7.
80. Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P. 2010. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10:832. http://dx.doi.org/10.1016/S1473-3099(10)70279-6.
81. Peirano G, Schreckenberger PC, Pitout JDD. 2011. Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob. Agents Chemother. 55:2986-2988. http://dx.doi.org/10.1128/AAC.01763-10.
82. Zong Z. 2013. Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain. Antimicrob. Agents Chemother. 57:597-600. http://dx.doi.org /10.1128/AAC.01081-12.
83. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, de Mendonca R, Jans B, Glupczynski Y. 2011. Trends in production of extended-spectrum β-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J. Antimicrob. Chemother. 66:37-47. http://dx.doi.org/10.1093/jac /dkq388.
84. Peirano G, van der Bij AK, Gregson DB, Pitout JD. 2012. Molecular epidemiology over an 11-year period (2000 to 2010) of extendedspectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J. Clin. Microbiol. 50:294-299. http://dx.doi.org/10.1128/JCM.06025-11.
85. Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD. 2010. High prevalence of ST131 producing CTX-M-15 and CTX-M-14 among extended-spectrum β-lactamase producing Escherichia coli across Canada. Antimicrob. Agents Chemother. 54:1327-1330. http://dx.doi.org/10.1128/AAC.01338-09.
86. Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, Andre C. 2009. Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting. J. Antimicrob. Chemother. 63:1205-1214. http://dx.doi.org/10.1093/jac/dkp108.
87. Izdebski R, Baraniak A, Fiett J, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M. 2013. Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob. Agents Chemother. 57: 309-316. http://dx.doi.org/10.1128/AAC.01656-12.
88. Voets GM, Platteel TN, Fluit AC, Scharringa J, Schapendonk CM, Stuart JC, Bonten MJ, Hall MA, National ESBL Surveillance Working Group. 2012. Population distribution of β-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 7:52102. http://dx.doi.org/10.1371 /journal.pone.0052102.
89. Pomba C, Lopez-Cerero L, Bellido M, Serrano L, Belas A, Couto N, Cavaco-Silva P, Rodriguez-Bano J, Pascual A. 2014. Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe. J. Antimicrob. Chemother. 69:271-273. http://dx.doi.org/10.1093/jac/dkt343.
90. Oteo J, Diestra K, Juan C, Bautista V, Novais A, Perez-Vazquez M, Moya B, Miro E, Coque TM, Oliver A, Canton R, Navarro F, Campos J. 2009. Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents. 34:173-176. http://dx.doi.org/10.1016/j.ijantimicag.2009.03.006.
91. Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, Kuffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A, Droz S, Muhlemann K. 2012. Transmission dynamics of extended-spectrum β-lactamaseproducing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin. Infect. Dis. 55:967-975. http://dx.doi.org/10.1093/cid /cis581.
92. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM. 2009. Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 64:635-641. http://dx.doi.org/10.1093/jac/dkp220.
93. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS, II, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. 2013. Community-associated extendedspectrum β-lactamase-producing Escherichia coli infection in the United States. Clin. Infect. Dis. 56:641-648. http://dx.doi.org/10.1093/cid /cis942.
94. Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentre F, Wolff M, Denamur E, Branger C. 2011. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin. Microbiol. Infect. 17:557-565. http://dx.doi.org/10.1111/j.1469-0691.2010.03298.x.
95. Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, Eriguchi Y, Nagasaki Y, Shimono N, Kang D. 2010. Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int. J. Antimicrob. Agents. 35: 444-450. http://dx.doi.org/10.1016/j.ijantimicag.2009.12.012.
96. Coelho A, Mora A, Mamani R, Lopez C, Gonzalez-Lopez JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J. 2011. Spread of Escherichia coli O25b: H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517-526. http://dx.doi.org/10.1093/jac/dkq491.
97. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y. 2012. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin. Infect. Dis. 55:224-231. http://dx.doi.org/10.1093/cid/cis387.
98. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. 2011. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 55:4933-4934. http://dx.doi.org/10.1128/AAC.00719-11.
99. Morris D, Boyle F, Ludden C, Condon I, Hale J, O'Connell N, Power L, Boo TW, Dhanji H, Lavallee C, Woodford N, Cormican M. 2011. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob. Agents Chemother. 55:4935-4936. http://dx.doi.org/10.1128/AAC.05127-11.
100. Cai JC, Zhang R, Hu YY, Zhou HW, Chen GX. 2014. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob. Agents Chemother. 58:1146-1152. http: //dx.doi.org/10.1128/AAC.00912-13.
101. Mantengoli E, Luzzaro F, Pecile P, Cecconi D, Cavallo A, Attala L, Bartoloni A, Rossolini GM. 2011. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin. Infect. Dis. 52:690-691. http://dx.doi.org/10.1093/cid/ciq194.
102. Yan J-J, Tsai L-H, Wu J-J. 2012. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan. Int. J. Antimicrob. Agents. 40:281-282. http://dx.doi.org/10.1016/j.ijantimicag.2012.05.011.
103. Naseer U, Olsson-Liljequist BE, Woodford N, Dhanji H, Canton R, Sundsfjord A, Lindstedt BA. 2012. Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones. PLoS One 7:e41232. http://dx.doi.org/10.1371/journal.pone.0041232.
104. Morris D, McGarry E, Cotter M, Passet V, Lynch M, Ludden C, Hannan MM, Brisse S, Cormican M. 2012. Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56:4030-4031. http: //dx.doi.org/10.1128/AAC.00638-12.
105. Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N. 2012. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J. Antimicrob. Chemother. 67:1660-1665. http://dx.doi.org/10.1093/jac/dks124.
106. Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E. 2013. Characterization of extended-spectrum β-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. J. Clin. Microbiol. 51:1727-1732. http://dx.doi.org/10.1128/JCM.03255-12.
107. Pitout JD, Gregson DB, Campbell L, Laupland KB. 2009. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of communityacquired infections. Antimicrob. Agents Chemother. 53:2846-2851. http://dx.doi.org/10.1128/AAC.00247-09.
108. Jones GL, Warren RE, Skidmore SJ, Davies VA, Gibreel T, Upton M. 2008. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extendedspectrum β-lactamases. J. Antimicrob. Chemother. 62:1245-1251. http: //dx.doi.org/10.1093/jac/dkn406.
109. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J. Antimicrob. Chemother. 67:346-356. http://dx.doi.org/10.1093/jac/dkr451.
110. Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A. 2013. Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a midwestern community. Infect. Control. Hosp. Epidemiol. 34:947-953. http://dx.doi.org/10.1086 /671725.
111. Vredenburg J, Varela AR, Hasan B, Bertilsson S, Olsen B, Narcisoda-Rocha C, Bonnedahl J, Stedt J, Da Costa PM, Manaia CM. 27 August 2013. Quinolone-resistant Escherichia coli isolated from birds of prey in Portugal are genetically distinct from those isolated from water environments and gulls in Portugal, Spain and Sweden. Environ. Microbiol. Rep. http://dx.doi.org/10.1111/1462-2920.12231.
112. Novais A, Rodrigues C, Branquinho R, Antunes P, Grosso F, Boaventura L, Ribeiro G, Peixe L. 2012. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur. J. Clin. Microbiol. Infect. Dis. 31:3057-3063. http://dx.doi.org/10.1007/s10096-012-1665-z.
113. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martinez-Martinez L. 2009. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6=)-Ib-cr genes in a dog. Antimicrob. Agents Chemother. 53:327-328. http: //dx.doi.org/10.1128/AAC.00896-08.
114. Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC, Duportail F, Heym B, Bingen E, Nicolas-Chanoine M-H. 2004. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 48:3736-3742. http://dx.doi.org/10.1128/AAC.48.10.3736-3742.2004.
115. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemice of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4(6):e00377-13. http://dx.doi.org /10.1128/mBio.00377-13.
116. Hirai I, Fukui N, Taguchi M, Yamauchi K, Nakamura T, Okano S, Yamamoto Y. 2013. Detection of chromosomal bla in Escherichia coli O25b-B2-ST131 isolates from the Kinki region of Japan. Int. J. Antimicrob. Agents. 42:500-506. http://dx.doi.org/10.1016/j.ijantimicag.2013.08.005.
117. Andersen PS, Stegger M, Aziz M, Contente-Cuomo T, Gibbons HS, Keim P, Sokurenko EV, Johnson JR, Price LB. 2013. Complete genome sequence of the epidemic and highly virulent CTX-M-15-producing H30-Rx subclone of Escherichia coli ST131. Genome Announc. 1(6): e00988-13. http://dx.doi.org/10.1128/genomeA.00988-13.
118. Williamson DA, Freeman JT, Porter S, Roberts S, Wiles S, Paterson DL, Johnson JR. 2013. Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. J. Antimicrob. Chemother. 68:2898-2906. http://dx.doi.org/10.1093/jac/dkt276.
119. Assimacopoulos A, Johnston B, Clabots C, Johnson JR. 2012. Postprostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli. J. Clin. Microbiol. 50:4157-4159. http://dx.doi.org/10.1128/JCM.02026-12.
120. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. 2010. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr. Infect. Dis. J. 29:473-475. http://dx.doi.org/10.1097 /INF.0b013e3181c89bd7.
121. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. 2010. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin. Infect. Dis. 50:374-380. http://dx.doi.org/10.1086/649866.
122. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR. 2009. Transmission of an extended-spectrum-β-lactamaseproducing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J. Clin. Microbiol. 47:3780-3782. http://dx.doi.org/10.1128/JCM.01361-09.
123. Owens RCJ, Johnson JR, Stogsdill P, Yarmus L, Lolans K, Quinn J. 2011. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J. Clin. Microbiol. 49:3406-3408. http://dx.doi.org/10.1128/JCM.00993-11.
124. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725. http://dx.doi.org/10.1128/JCM.01581-09.
125. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028. http://dx.doi.org/10.1093/jac/dkn084.
126. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, Upton M. 2012. High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J. Clin. Microbiol. 50:3202-3207. http://dx.doi.org/10.1128/JCM.01423-12.
127. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, Garry L, Clermont O, Denamur E, Arlet G, Vandewalle A. 2012. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. http://dx.doi.org/10.1371/journal.pone.0046547.
128. Martinez-Medina M, Mora A, Blanco M, Lopez C, Alonso MP, Bonacorsi S, Nicolas-Chanoine MH, Darfeuille-Michaud A, Garcia-Gil J, Blanco J. 2009. Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains. J. Clin. Microbiol. 47:3968-3979. http://dx.doi.org/10.1128/JCM.01484-09.
129. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, Bachmann N, Szubert M, Sidjabat HE, Paterson DL, Upton M, Schrembi MA. 2011. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6:e26578. http://dx.doi.org/10.1371/journal.pone.0026578.
130. Peirano G, Mulvey GL, Armstrong GD, Pitout JD. 2013. Virulence potential and adherence properties of Escherichia coli that produce CTX-M andNDMbeta-lactamases. J. Med. Microbiol. 62:525-530. http: //dx.doi.org/10.1099/jmm.0.048983-0.
131. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect. Immun. 80:1554-1562. http://dx.doi.org/10.1128/IAI.06388-11.
132. Avasthi TS, Kumar N, Baddam R, Hussain A, Nandanwar N, Jadhav S, Ahmed N. 2011. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J. Bacteriol. 193:4272-4273. http: //dx.doi.org/10.1128/JB.05413-11.
133. Clark G, Paszkiewicz K, Hale J, Weston V, Constantinidou C, Penn C, Achtman M, McNally A. 2012. Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. J. Antimicrob. Chemother. 67:868-877. http://dx.doi.org/10.1093/jac/dkr585.
134. Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, Wieler LH, Ewers C, Ahmed N. 2011. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One 6:e18063. http://dx.doi.org/10.1371/journal.pone.0018063.
135. Phan M-D, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, Gomes Moriel D, Achard MES, Totsika M, Marshall VM, Upton M, Beatson SA, Schembri MA. 2013. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet. 9:e1003834. http://dx.doi.org/10.1371/journal.pgen.1003834.
136. Croxall G, Weston V, Joseph S, Manning G, Cheetham P, McNally A. 2011. Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J. Med. Microbiol. 60:102-109. http: //dx.doi.org/10.1099/jmm.0.020602-0.
137. McNally A, Cheng L, Harris SR, Corander J. 2013. The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome. Genome Biol. Evol. 5:699-710. http://dx.doi.org/10.1093/gbe /evt038.
138. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, Lopez C, Cortes P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, Garcia-Garrote F, Pita JM, Blanco J. 2009. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 63:1135-1141. http://dx.doi.org/10.1093/jac/dkp122.
139. Xu L, Shabir S, Bodah T, McMurray C, Hardy K, Hawkey P, Nye K. 2011. Regional survey of CTX-M-type extended-spectrum β-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone. J. Antimicrob. Chemother. 66:505-511. http: //dx.doi.org/10.1093/jac/dkq482.
140. Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagace-Wiens PR, Adam HJ, Hoban DJ. 2011. Prevalence and characterization of extended-spectrum β-lactamase-and AmpC β-lactamaseproducing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn. Microbiol. Infect. Dis. 69:326-334. http://dx.doi.org/10.1016/j.diagmicrobio.2010.10.029.
141. Chandramohan L, Revell PA. 2012. Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob. Agents Chemother. 56:4765-4770. http://dx.doi.org/10.1128/AAC.00666-12.
142. Yano H, Uemura M, Endo S, Kanamori H, Inomata S, Kakuta R, Ichimura S, Ogawa M, Shimojima M, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kunishima H, Kitagawa M, Hirakata Y, Kaku M. 2013. Molecular characteristics of extended-spectrum β-Lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital. PLoS One 8:e64359. http://dx.doi.org/10.1371/journal.pone.0064359.
143. Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Tegmark Wisell K, Giske CG. 3 October 2013. Epidemiology of ESBLproducing Escherichia coli in Sweden 2007-2011. Clin. Microbiol. Infect. http://dx.doi.org/10.1111/1469-0691.12413.
144. Reyna-Flores F, Barrios H, Garza-Ramos U, Sanchez-Perez A, Rojas-Moreno T, Uribe-Salas FJ, Fagundo-Sierra R, Silva-Sanchez J. 2013. Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico. Diagn. Microbiol. Infect. Dis. 76: 396-398. http://dx.doi.org/10.1016/j.diagmicrobio.2013.03.026.
145. Peirano G, Hung King Sang J, Pitondo-Silva A, Laupland KB, Pitout JDD. 2012. Molecular epidemiology of extended-spectrum β-lactamaseproducing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J. Antimicrob. Chemother. 67:1114-1120. http://dx.doi.org/10.1093/jac/dks026.
146. Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, Peck KR, Lee NY, Song J-H. 2013. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamaseproducing Escherichia coli over a 6-year period. J. Korean Med. Sci. 28: 998-1004. http://dx.doi.org/10.3346/jkms.2013.28.7.998.
147. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB. 2009. Molecular characteristics of travel-related extended-spectrum-β-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob. Agents Chemother. 53:2539-2543. http://dx.doi.org/10.1128/AAC.00061-09.
148. Peirano G, Laupland KB, Gregson DB, Pitout JD. 2011. Colonization of returning travelers with CTX-M-producing Escherichia coli. J. Travel Med. 18:299-303. http://dx.doi.org/10.1111/j.1708-8305.2011.00548.x.
149. Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim SW, Chang HH, Jung SI, Kim YS, Ki HK, Son JS, Kwon KT, Heo ST, Yeom JS, Shin SY, Chung DR, Peck KR, Song JH, Ko KS. 2010. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J. Infect. 60:146-153. http://dx.doi.org/10.1016/j.jinf.2009.11.004.
150. Rogers BA, Kennedy KJ, Sidjabat HE, Jones M, Collignon P, Paterson DL. 2012. Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics. Eur. J. Clin. Microbiol. Infect. Dis. 31:2413-2420. http://dx.doi.org/10.1007/s10096-012-1584-z.
151. Tangden T, Cars O, Melhus A, Lowdin E. 2010. Foreign travel is a major risk factor for colonization with Escherichia coli producing extendedspectrum β-lactamases of the CTX-M type: a prospective study on Swedish volunteers. Antimicrob. Agents Chemother. 54:3564-3568. http://dx.doi.org/10.1128/AAC.00220-10.
152. Freeman JT, McBride SJ, Hefferman H, Bathgate T, Pope C, Ellis-Pegler R. 2008. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli travelers to the Indian Subcontinent in New Zeland. Clin. Infect. Dis. 47:689-692. http://dx.doi.org/10.1086/590941.
153. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. 2008. Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel. J. Infect. 57:441-448. http://dx.doi.org/10.1016/j.jinf.2008.09.034.
154. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, Debroy C, Nowicki B, Rice J. 2010. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob. Agents Chemother. 54:546-550. http: //dx.doi.org/10.1128/AAC.01089-09.
155. Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, Garcia-Garrote F, Chaves F, Orellana MA, Martinez-Martinez L, Calvo J, Prats G, Larrosa MN, Gonzalez-Lopez JJ, Lopez-Cerero L, Rodriguez-Bano J, Pascual A. 2011. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66:2011-2021. http://dx.doi.org/10.1093/jac/dkr235.
156. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. 2013. Escherichia coli sequence type 131 is a dominant, antimicrobialresistant clonal group associated with healthcare and elderly hosts. Infect. Control. Hosp. Epidemiol. 34:361-369. http://dx.doi.org/10.1086 /669865.
157. Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, Marcon E, Valla D, Moreau R, Nicolas-Chanoine MH. 2010. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J. Clin. Microbiol. 48:2709-2714. http://dx.doi.org/10.1128/JCM.00516-10.
158. Horner C, Fawley W, Morris K, Parnell P, Denton M, Wilcox M. 2014. Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12). J. Antimicrob. Chemother. 69:91-100. http://dx.doi.org/10.1093/jac/dkt333.
159. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr. Infect. Dis. J. 32:543-548. http://dx.doi.org/10.1097/INF.0b013e31828ba3f1.
160. Chmielarczyk A, Pobiega M, Wojkowska-Mach J, Romaniszyn D, Adamski P, Heczko PB, Bulanda M. 2013. Molecular epidemiology, plasmid analysis, virulence, and resistance of Escherichia coli isolated from neonatal intensive care units in Poland. Diagn. Microbiol. Infect. Dis. 76:542-545. http://dx.doi.org/10.1016/j.diagmicrobio.2013.04.016.
161. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR. 2013. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and-negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob. Agents Chemother. 57:6385-6388. http://dx.doi.org/10.1128/AAC.01604-13.
162. Chung H-C, Lai C-H, Lin J-N, Huang C-K, Liang S-H, Chen W-F, Shih Y-C, Lin H-H, Wang J-L. 2012. Bacteremia caused by extendedspectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob. Agents Chemother. 56:618-622. http: //dx.doi.org/10.1128/AAC.05753-11.
163. Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S. 2013. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. Eur. J. Clin. Microbiol. Infect. Dis. 32:513-521. http://dx.doi.org /10.1007/s10096-012-1765-9.
164. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. 2011. High prevalence of CTX-M β-lactamases in feacal Escherichia coli strains from healthy humans in Fuzhou, China. Scand. J. Infect. Dis. 43:170-174. http://dx.doi.org/10.3109/00365548.2010.538856.
165. Nicolas-Chanoine M-H, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V. 2013. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J. Antimicrob. Chemother. 68:562-568. http://dx.doi.org/10.1093/jac/dks429.
166. Arvand M, Moser V, Pfeifer Y. 2013. Prevalence of extended-spectrum-β-lactamase-producing Escherichia coli and spread of the epidemic clonal lineage ST131 in nursing homes in Hesse, Germany. J. Antimicrob. Chemother. 68:2686-2688. http://dx.doi.org/10.1093/jac/dkt226.
167. Nuesch-Inderbinen MT, Abgottspon H, Zurfluh K, Nuesch HJ, Stephan R, Hachler H. 2013. Cross-sectional study on fecal carriage of Enterobacteriaceae with resistance to extended-spectrum cephalosporins in primary care patients. Microb. Drug Resist. 19:362-369. http://dx.doi.org/10.1089/mdr.2013.0013.
168. Severin JA, Lestari ES, Kloezen W, Lemmens-den Toom N, Mertaniasih NM, Kuntaman K, Purwanta M, Offra Duerink D, Hadi U, van Belkum A, Verbrugh HA, Goessens WH. 2012. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002. Trop. Med. Int. Health 17:455-461. http://dx.doi.org/10.1111/j.1365-3156.2011.02949.x.
169. Johnson JR, Clabots C. 2006. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin. Infect. Dis. 43:101-108. http://dx.doi.org/10.1086/508541.
170. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-β-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65:651-660. http://dx.doi.org/10.1093/jac /dkq004.
171. Harada K, Nakai Y, Kataoka Y. 2012. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTXM-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan. Microbiol. Immunol. 56:480-485. http://dx.doi.org/10.1111/j.1348-0421.2012.00463.x.
172. Platell JL, Cobbold RN, Johnson JR, Trott DJ. 2010. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J. Antimicrob. Chemother. 65: 1936-1938. http://dx.doi.org/10.1093/jac/dkq236.
173. Guo S, Brouwers HJM, Cobbold RN, Platell JL, Chapman TA, Barrs VR, Johnson JR, Trott DJ. 2013. Fluoroquinolone-resistant extraintestinal pathogenic Escherichia coli, including O25b-ST131, isolated from faeces of hospitalized dogs in an Australian veterinary referral centre. J. Antimicrob. Chemother. 68:1025-1031. http://dx.doi.org/10.1093/jac /dks515.
174. Huber H, Zweifel C, Wittenbrink MM, Stephan R. 2013. ESBLproducing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland. Vet. Microbiol. 162:992-996. http://dx.doi.org/10.1016/j.vetmic.2012.10.029.
175. Tamang MD, Nam HM, Jang GC, Kim SR, Chae MH, Jung SC, Byun JW, Park YH, Lim SK. 2012. Molecular characterization of extendedspectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolated from stray dogs in South Korea. Antimicrob. Agents Chemother. 56:2705-2712. http://dx.doi.org/10.1128/AAC.05598-11.
176. Dierikx CM, van Duijkeren E, Schoormans AH, van Essen-Zandbergen A, Veldman K, Kant A, Huijsdens XW, van der Zwaluw K, Wagenaar JA, Mevius DJ. 2012. Occurrence and characteristics of extended-spectrum-β-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 67:1368-1374. http://dx.doi.org/10.1093/jac/dks049.
177. Albrechtova K, Dolejska M, Cizek A, Tausova D, Klimes J, Bebora L, Literak I. 2012. Dogs of nomadic pastoralists in northern Kenya are reservoirs of plasmid-mediated cephalosporin-and quinolone-resistant Escherichia coli, including pandemic clone B2-O25-ST131. Antimicrob. Agents Chemother. 56:4013-4017. http://dx.doi.org/10.1128/AAC.05859-11.
178. Schink AK, Kadlec K, Kaspar H, Mankertz J, Schwarz S. 2013. Analysis of extended-spectrum-β-lactamase-producing Escherichia coli isolates collected in the GERM-Vet. monitoring programme. J. Antimicrob. Chemother. 68:1741-1749. http://dx.doi.org/10.1093/jac/dkt123.
179. Wu G, Day MJ, Mafura MT, Nunez-Garcia J, Fenner JJ, Sharma M, van Essen-Zandbergen A, Rodriguez I, Dierikx C, Kadlec K, Schink AK, Wain J, Helmuth R, Guerra B, Schwarz S, Threlfall J, Woodward MJ, Woodford N, Coldham N, Mevius D. 2013. Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany. PLoS One 8:75392. http://dx.doi.org/10.1371/journal.pone.0075392.
180. Randall LP, Clouting C, Horton RA, Coldham NG, Wu G, Clifton-Hadley FA, Davies RH, Teale CJ. 2011. Prevalence of Escherichia coli carrying extended-spectrum β-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009. J. Antimicrob. Chemother. 66:86-95. http://dx.doi.org/10.1093/jac /dkq396.
181. Cortes P, Blanc V, Mora A, Dahbi G, Blanco JE, Blanco M, Lopez C, Andreu A, Navarro F, Alonso MP, Bou G, Blanco J, Llagostera M. 2010. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76:2799-2805. http://dx.doi.org/10.1128 /AEM.02421-09.
182. Giuffre M, Cipolla D, Bonura C, Geraci DM, Aleo A, Di Noto S, Nociforo F, Corsello G, Mammina C. 2013. Outbreak of colonizations by extended-spectrum b-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy. Antimicrob. Resist. Infect. Control. 2:8. http://dx.doi.org/10.1186/2047-2994-2-8.
183. Dahmen S, Metayer V, Gay E, Madec JY, Haenni M. 2013. Characterization of extended-spectrum β-lactamase (ESBL)-carrying plasmids and clones of Enterobacteriaceae causing cattle mastitis in France. Vet. Microbiol. 162:793-799. http://dx.doi.org/10.1016/j.vetmic.2012.10.015.
184. Hordijk J, Wagenaar JA, van de Giessen A, Dierikx C, van Essen-Zandbergen A, Veldman K, Kant A, Mevius DJ. 2013. Increasing prevalence and diversity of ESBL/AmpC-type β-lactamase genes in Escherichia coli isolated from veal calves from 1997 to 2010. J. Antimicrob. Chemother. 68:1970-1973. http://dx.doi.org/10.1093/jac/dkt132.
185. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ. 2011. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin. Microbiol. Infect. 17:873-880. http: //dx.doi.org/10.1111/j.1469-0691.2011.03497.x.
186. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, Heck M, Savelkoul P, Vandenbroucke-Grauls C, Van der Zwaluw K, Huijsdens X, Kluytmans J. 2011. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg. Infect. Dis. 17:1216-1222. http://dx.doi.org/10.3201/eid1707.110209.
187. CTX-M-15-carrying plasmids. J. Antimicrob. Chemother. 67:578-581. http://dx.doi.org/10.1093/jac/dkr542.
188. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, Chen X, Lv L, Zhuo C, Chen Z, Liu J-H. 2012. Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int. J. Antimicrob. Agents. 39:305-310. http://dx.doi.org/10.1016/j.ijantimicag.2011.12.001.
189. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier PP, Tellis PA, Ziebell K, Manges AR. 2010. Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 16:88-95. http://dx.doi.org/10.3201/eid1601.091118.
190. Dhanji H, Murphy NM, Doumith M, Durmus S, Lee SS, Hope R, Woodford N, Livermore DM. 2010. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J. Antimicrob. Chemother. 65:2534-2537. http://dx.doi.org/10.1093/jac /dkq376.
191. Egea P, Lopez-Cerero L, Torres E, Gomez-Sanchez Mdel C, Serrano L, Navarro Sanchez-Ortiz MD, Rodriguez-Bano J, Pascual A. 2012. Increased raw poultry meat colonization by extended spectrum β-lactamase-producing Escherichia coli in the South of Spain. Int. J. Food Microbiol. 159:69-73. http://dx.doi.org/10.1016/j.ijfoodmicro.2012.08.002.
192. CTX-M-15, found in Glaucous-winged gull at remote Commander Islands, Russia. Environ. Microbiol. Rep. 2:329-332. http://dx.doi.org/10.1111/j.1758-2229.2010.00142.x.
193. Simoes RR, Poirel L, Da Costa PM, Nordmann P. 2010. Seagulls and beaches as reservoirs for multidrug-resistant Escherichia coli. Emerg. Infect. Dis. 16:110-112. http://dx.doi.org/10.3201/eid1601.090896.
194. Tausova D, Dolejska M, Cizek A, Hanusova L, Hrusakova J, Svoboda O, Camlik G, Literak I. 2012. Escherichia coli with extended-spectrum β-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe. J. Antimicrob. Chemother. 67:1103-1107. http://dx.doi.org/10.1093/jac/dks017.
195. Guenther S, Grobbel M, Beutlich J, Guerra B, Ulrich RG, Wieler LH, Ewers C. 2010. Detection of pandemic B2-O25-ST131 Escherichia coli harbouring the CTX-M-9 extended-spectrum β-lactamase type in a feral urban brown rat (Rattus norvegicus). J. Antimicrob. Chemother. 65: 582-584. http://dx.doi.org/10.1093/jac/dkp496.
196. CTX-M IncFII plasmids and clones of Escherichia coli from pets in France. J. Antimicrob. Chemother. 68:2797-2801. http://dx.doi.org/10.1093/jac/dkt291.
197. Giufre M, Graziani C, Accogli M, Luzzi I, Busani L, Cerquetti M. 2012. Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. J. Antimicrob. Chemother. 67:860-867. http://dx.doi.org/10.1093/jac /dkr565.
198. Trobos M, Christensen H, Sunde M, Nordentoft S, Agerso Y, Simonsen GS, Hammerum AM, Olsen JE. 2009. Characterization of sulphonamide-resistant Escherichia coli using comparison of sul2 gene sequences and multilocus sequence typing. Microbiology 155:831-836. http://dx.doi.org/10.1099/mic.0.024190-0.
199. Guenther S, Ewers C, Wieler LH. 2011. Extended-spectrum β-lactamases producing E. coli in wildlife, yet another form of environmental pollution? Front. Microbiol. 2:246. http://dx.doi.org/10.3389/fmicb.2011.00246.
200. Platell JL, Johnson JR, Cobbold RN, Trott DJ. 2011. Multidrugresistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet. Microbiol. 153:99-108. http://dx.doi.org/10.1016/j.vetmic.2011.05.007.
201. Jakobsen L, Sandvang D, Hansen LH, Bagger-Skjot L, Westh H, Jorgensen C, Hansen DS, Pedersen BM, Monnet DL, Frimodt-Moller N, Sorensen SJ, Hammerum AM. 2008. Characterisation, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment. Environ. Int. 34:108-115. http://dx.doi.org/10.1016/j.envint.2007.07.011.
202. Galvin S, Boyle F, Hickey P, Vellinga A, Morris D, Cormican M. 2010. Enumeration and characterization of antimicrobial-resistant Escherichia coli bacteria in effluent from municipal, hospital, and secondary treatment facility sources. Appl. Environ. Microbiol. 76:4772-4779. http://dx.doi.org/10.1128/AEM.02898-09.
203. Mesa RJ, Blanc V, Blanch AR, Cortes P, Gonzalez JJ, Lavilla S, Miro E, Muniesa M, Saco M, Tortola MT, Mirelis B, Coll P, Llagostera M, Prats G, Navarro F. 2006. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J. Antimicrob. Chemother. 58:211-215. http://dx.doi.org/10.1093/jac/dkl211.
204. Zarfel G, Galler H, Feierl G, Haas D, Kittinger C, Leitner E, Grisold AJ, Mascher F, Posch J, Pertschy B, Marth E, Reinthaler FF. 2013. Comparison of extended-spectrum-β-lactamase (ESBL) carrying Escherichia coli from sewage sludge and human urinary tract infection. Environ. Pollut. 173:192-199. http://dx.doi.org/10.1016/j.envpol.2012.09.019.
205. Colomer-Lluch M, Mora A, Lopez C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M, Alonso MP, Jofre J, Muniesa M, Blanco J. 2013. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain. J. Antimicrob. Chemother. 68:758-765. http://dx.doi.org/10.1093/jac/dks477.
206. Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Guenther ACS, Literak I. 2011. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J. Antimicrob. Chemother. 66: 2784-2786. http://dx.doi.org/10.1093/jac/dkr363.
207. Vignaroli C, Luna GM, Pasquaroli S, Di Cesare A, Petruzzella R, Paroncini P, Biavasco F. 2013. Epidemic Escherichia coli ST131 and Enterococcus faecium ST17 in coastal marine sediments from an Italian beach. Environ. Sci. Technol. 47:13772-13780. http://dx.doi.org/10.1021/es4019139.
208. Nicolas-Chanoine M-H, Robert J, Vigan M, Laouenan C, Brisse S, Mentre F, Jarlier V. 2013. Different factors associated with CTX-Mproducing ST131 and non-ST131 Escherichia coli clinical isolates. PLoS One 8:e72191. http://dx.doi.org/10.1371/journal.pone.0072191.
209. Kluytmans JA, Overdevest ITM, Willemsen I, Kluytmans-van den Bergh MF, van der Zwaluw K, Heck M, Rijnsburger M, Vandenbroucke-Grauls CM, Savelkoul PHM, Johnston BD, Gordon D, Johnson JR. 2013. Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin. Infect. Dis. 56:478-487. http://dx.doi.org/10.1093/cid/cis929.
210. Cohen Stuart J, van den Munckhof T, Voets G, Scharringa J, Fluit A, Hall ML. 2012. Comparison of ESBL contamination in organic and conventional retail chicken meat. Int. J. Food Microbiol. 154:212-214. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.12.034.
211. Nicolas-Chanoine M-H, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F, Study Group Coli β. 2012. Patient's origin and lifestyle associated with CTX-Mproducing Escherichia coli: a case-control-control study. PLoS One 7:e30498. http://dx.doi.org/10.1371/journal.pone.0030498.
212. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, Almela M, Almirante B, Grill F, Colomina J, Molinos S, Oliver A, Fernandez-Mazarrasa C, Navarro G, Coloma A, Lopez-Cerero L, Pascual A. 2010. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli. J. Clin. Microbiol. 48:1726-1731. http://dx.doi.org/10.1128 /JCM.02353-09.
213. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Ruiz M, Pena C, Almela M, Almirante B, Grill F, Colomina J, Gimenez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A. 2010. Communityonset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48. http://dx.doi.org/10.1086/649537.
214. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52:103-120. http://dx.doi.org/10.1093/cid/ciq257.
215. Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martinez-Ruiz R, Perez-Vazquez M, Alcaraz M, Garcia-Cobos S, Campos J. 2009. CTXM-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J. Antimicrob. Chemother. 64: 712-717. http://dx.doi.org/10.1093/jac/dkp288.
216. Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S. 2012. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob. Agents Chemother. 56:3568-3575. http://dx.doi.org/10.1128/AAC.06330-11.
217. Totsika M, Kostakioti M, Hannan TJ, Upton M, Beatson SA, Janetka JW, Hultgren SJ, Schembri MA. 2013. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrugresistant uropathogenic Escherichia coli ST131. J. Infect. Dis. 208:921-928. http://dx.doi.org/10.1093/infdis/jit245.
218. Pitout JD. 2010. Infections with ESBL-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333. http://dx.doi.org/10.2165/11533040-000000000-00000.
219. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents. 35:316-321. http://dx.doi.org /10.1016/j.ijantimicag.2009.11.003.
220. CTX-M-15) genetic structures. Antimicrob. Agents Chemother. 53:1630-1635. http://dx.doi.org/10.1128/AAC.01431-08.
221. Nielsen JB, Albayati A, Jorgensen RL, Hansen KH, Lundgren B, Schonning K. 2013. An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area. Eur. J. Clin. Microbiol. Infect. Dis. 32:431-436. http://dx.doi.org/10.1007/s10096-012-1764-x.
222. Cerquetti M, Giufre M, Garcia-Fernandez A, Accogli M, Fortini D, Luzzi I, Carattoli A. 2010. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin. Microbiol. Infect. 16:1555-1558. http://dx.doi.org/10.1111/j.1469-0691.2010.03162.x.
223. van der Bij AK, Peirano G, Goessens WH, van der Vorm ER, van Westreenen M, Pitout JD. 2011. Clinical and molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob. Agents Chemother. 55:3576-3578. http://dx.doi.org/10.1128/AAC.00074-11.
224. Woksepp H, Jernberg C, Tarnberg M, Ryberg A, Brolund A, Nordvall M, Olsson-Liljequist B, Wisell KT, Monstein H-J, Nilsson L, Schon T. 2011. High-resolution melting-curve analysis of ligation-mediated realtime PCR for rapid evaluation of an epidemiological outbreak of extended-spectrum-β-lactamase-producing Escherichia coli. J. Clin. Microbiol. 49:4032-4039. http://dx.doi.org/10.1128/JCM.01042-11.
225. CTX-M-carrying Escherichia coli of the O25b ST131 clonal group have emerged in China. Diagn. Microbiol. Infect. Dis. 69:228-231. http://dx.doi.org/10.1016/j.diagmicrobio.2010.10.007.
226. Ho P-L, Lo WU, Lai EL, Chow K-H, Yam W-C. 2012. Escherichia coli O25b-ST131 is an important cause of antimicrobial-resistant infections in women with uncomplicated cystitis. J. Antimicrob. Chemother. 67: 2534-2535. http://dx.doi.org/10.1093/jac/dks248.
227. Roy S, Krishnan R, Mukherjee S, Schneiders T, Niyogi SK, Basu S. 2013. Prevalence of ST131 virulence-associated strains among CTX-Mproducing Escherichia coli in the gut of hospitalized neonates in India. Diagn. Microbiol. Infect. Dis. 77:158-159. http://dx.doi.org/10.1016/j.diagmicrobio.2013.06.014.
228. Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, Malhotra-Kumar S, Goossens H, Lammens C, Lerman Y, Kazma M, Kotlovsky T, Carmeli Y, groups MWaWs. 2012. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin. Microbiol. Infect. 18:E497-E505.
229. Yokota S-i, Sato T, Okubo T, Ohkoshi Y, Okabayashi T, Kuwahara O, Tamura Y, Fujii N. 2012. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. Chemotherapy 58:52-59. http://dx.doi.org/10.1159/000336129.
230. Yumuk Z, Afacan G, Nicolas-Chanoine M-H, Sotto A, Lavigne JP. 2008. Turkey: a further country concerned by community acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 62:284-288. http://dx.doi.org/10.1093/jac/dkn181.
231. Szijarto V, Pal T, Nagy G, Nagy E, Ghazawi A, al-Haj M, El Kurdi S, Sonnevend A. 2012. The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type. FEMS Microbiol. Lett. 332:131-136. http://dx.doi.org/10.1111/j.1574-6968.2012.02585.x.
232. Tiruvury H, Johnson JR, Mariano N, Grenner L, Colon-Urban R, Erritouni M, Wehbeh W, Segal-Maurer S, Rahal JJ, Johnston B, Urban C. 2012. Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City. Diagn. Microbiol. Infect. Dis. 72:248-252. http://dx.doi.org/10.1016/j.diagmicrobio.2011.11.008.
233. Sennati S, Santella G, Di Conza J, Pallecchi L, Pino M, Ghiglione B, Rossolini GM, Radice M, Gutkind G. 2012. Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15. Antimicrob. Agents Chemother. 56:6003-6005. http://dx.doi.org/10.1128/AAC.00745-12.
234. Peirano G, Asensi MD, Pitondo-Silva A, Pitout JD. 2011. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. Clin. Microbiol. Infect. 17:1039-1043. http://dx.doi.org/10.1111/j.1469-0691.2010.03440.x.
235. Ruiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceno DF, Martinez E, Rosso F, Munoz M, Quinn JP, Canton R, Villegas MV. 2011. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J. Clin. Microbiol. 49:1993-1996. http://dx.doi.org/10.1128 /JCM.00045-11.
236. Molina-Lopez J, Aparicio-Ozores G, Ribas-Aparicio RM, Gavilanes-Parra S, Chavez-Berrocal ME, Hernandez-Castro R, Manjarrez-Hernandez HA. 2011. Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J. Infect. Dev. Ctries. 5:840-849. http://dx.doi.org/10.3855 /jidc.1703.
237. Magoue CL, Melin P, Gangoue-Pieboji J, Okomo Assoumou MC, Boreux R, De Mol P. 2013. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Ngaoundere, Cameroon. Clin. Microbiol. Infect. 19:E416-E420. http://dx.doi.org/10.1111/1469-0691.12239.
238. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine M-H. 2011. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb. Drug Resist. 17:67-73. http://dx.doi.org/10.1089/mdr.2010.0063.
239. Rakotonirina HC, Garin B, Randrianirina F, Richard V, Talarmin A, Arlet G. 2013. Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiol. 13:85. http://dx.doi.org/10.1186/1471-2180-13-85.
240. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B. 2012. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clin. Microbiol. Infect. 18:E49-E51. http://dx.doi.org/10.1111/j.1469-0691.2011.03730.x.
241. Peirano G, van Greune CHJ, Pitout JDD. 2011. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn. Microbiol. Infect. Dis. 69:449-453. http://dx.doi.org/10.1016/j.diagmicrobio.2010.11.011.
242. CTX-M-15 in a tertiary hospital in Tanzania. Clin. Microbiol. Infect. 17:1279-1282. http://dx.doi.org/10.1111/j.1469-0691.2011.03518.x.
243. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallegue O, Arlet G. 2010. Characterization and molecular epidemiology of extendedspectrum β-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian university hospital. Microb. Drug Resist. 16:163-170. http://dx.doi.org/10.1089/mdr.2009.0108.
244. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin. Microbiol. Infect. 19:E173-E180. http://dx.doi.org/10.1111/1469-0691.12123.
245. Sidjabat HE, Derrington P, Nimmo GR, Paterson DL. 2010. Escherichia coli ST131 producing CTX-M-15 in Australia. J. Antimicrob. Chemother. 65:1301-1303. http://dx.doi.org/10.1093/jac/dkq098.
246. Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, Rice M, Freeman JT. 2012. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin. Infect. Dis. 54:1406-1412. http://dx.doi.org/10.1093/cid /cis194.